Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT - Nasdaq - US1314281049 - Common Stock - Currency: USD

16.43  -0.45 (-2.67%)

After market: 16.43 0 (0%)

Fundamental Rating

1

Taking everything into account, CLMT scores 1 out of 10 in our fundamental rating. CLMT was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT may be in some trouble as it scores bad on both profitability and health. CLMT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
CLMT had a negative operating cash flow in the past year.
CLMT had negative earnings in 4 of the past 5 years.
In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -13.60%, CLMT is not doing good in the industry: 88.26% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

In the last couple of years the Operating Margin of CLMT has declined.
The Gross Margin of CLMT (2.88%) is worse than 76.53% of its industry peers.
In the last couple of years the Gross Margin of CLMT has declined.
The Profit Margin and Operating Margin are not available for CLMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.88%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

1

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLMT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLMT has been increased compared to 5 years ago.
The debt/assets ratio for CLMT is higher compared to a year ago.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
CLMT's Altman-Z score of 1.13 is in line compared to the rest of the industry. CLMT outperforms 44.60% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC8.47%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CLMT has a Current Ratio of 1.06. This is a normal value and indicates that CLMT is financially healthy and should not expect problems in meeting its short term obligations.
CLMT has a Current ratio (1.06) which is comparable to the rest of the industry.
CLMT has a Quick Ratio of 1.06. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLMT has a Quick ratio of 0.61. This is in the lower half of the industry: CLMT underperforms 73.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.61
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CLMT have decreased strongly by -6642.86% in the last year.
CLMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.90%.
CLMT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.94% yearly.
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%

3.2 Future

Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.17% on average per year.
Based on estimates for the next years, CLMT will show a small growth in Revenue. The Revenue will grow by 7.25% on average per year.
EPS Next Y51.25%
EPS Next 2Y41.81%
EPS Next 3Y28.93%
EPS Next 5Y29.17%
Revenue Next Year-4.08%
Revenue Next 2Y-1.43%
Revenue Next 3Y5.54%
Revenue Next 5Y7.25%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 568.58, which means the current valuation is very expensive for CLMT.
Based on the Price/Forward Earnings ratio, CLMT is valued a bit more expensive than the industry average as 70.89% of the companies are valued more cheaply.
CLMT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 568.58
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400 500

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than the industry average as 74.18% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 82.75
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CLMT's earnings are expected to grow with 28.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.81%
EPS Next 3Y28.93%

More info and screens

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (6/18/2025, 8:00:00 PM)

After market: 16.43 0 (0%)

16.43

-0.45 (-2.67%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners46.21%
Inst Owner Change6.41%
Ins Owners3.14%
Ins Owner Change1.55%
Market Cap1.42B
Analysts78.46
Price Target19.38 (17.95%)
Short Float %12.54%
Short Ratio7.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-158.08%
Min EPS beat(2)-346.52%
Max EPS beat(2)30.36%
EPS beat(4)2
Avg EPS beat(4)-89.27%
Min EPS beat(4)-346.52%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)76.92%
EPS beat(12)5
Avg EPS beat(12)-483.8%
EPS beat(16)7
Avg EPS beat(16)-347.91%
Revenue beat(2)2
Avg Revenue beat(2)5.15%
Min Revenue beat(2)0.99%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)8.63%
Min Revenue beat(4)0.99%
Max Revenue beat(4)13.26%
Revenue beat(8)7
Avg Revenue beat(8)7.42%
Revenue beat(12)11
Avg Revenue beat(12)9.08%
Revenue beat(16)15
Avg Revenue beat(16)11.52%
PT rev (1m)-7.32%
PT rev (3m)-26.21%
EPS NQ rev (1m)-0.32%
EPS NQ rev (3m)-220.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-3309.92%
Revenue NQ rev (1m)5.15%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)6.13%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 568.58
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 82.75
EPS(TTM)-4.72
EYN/A
EPS(NY)0.03
Fwd EY0.18%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS59.84
BVpS-9.95
TBVpS-9.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.88%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score3
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 47.76
Cap/Depr 49.87%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.61
Altman-Z 1.13
F-Score3
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
EPS Next Y51.25%
EPS Next 2Y41.81%
EPS Next 3Y28.93%
EPS Next 5Y29.17%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%
Revenue Next Year-4.08%
Revenue Next 2Y-1.43%
Revenue Next 3Y5.54%
Revenue Next 5Y7.25%
EBIT growth 1Y-138.21%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3176.38%
EBIT Next 3Y277.46%
EBIT Next 5Y146.58%
FCF growth 1Y73.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-182.03%
OCF growth 3YN/A
OCF growth 5YN/A